16 de junio de 2019
  • Sábado, 15 de Junio
  • Viernes, 14 de Junio
  • 11 de junio de 2019

    New Study Shows Rifaximin Significantly Reduced the Number and Length of Hospitalisations in Patients With Overt Hepatic

    1. Salehi S, Tranah TH, Lim S, et al. Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list. Aliment Pharmacol Ther. 2019;00:1-7. https://doi.org/10.1111/apt.15326 [https://doi.org/10.1111/apt.15326] [Last accessed: June 2019] 2. Morgan M. Chapter 8: Hepatic Encephalopathy in Patients with Cirrhosis. In: Dooley JS, Lok A, Burroughs A, Heathcote J, editors. Sherlock's Diseases of the Liver and Biliary System. 12th ed: Blackwell Publishing Ltd; 2011 3. Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. Journal of Hepatology 2014; 61(3):642-659 4. Mullen KD. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther. 2007 Feb; 25 Suppl 1:11-6 5. Morgan, C.LI et al, Mortality associated with hepatic encephalopathy in patients with severe liver disease, Journal of Hepatology 2014; 60 (Abstract P452): S219

    GL/COR/0519/0189, Date of preparation June 2019

    Logo -- http://mma.prnewswire.com/media/597589/Norgine_Logo.jpg [http://mma.prnewswire.com/media/597589/Norgine_Logo.jpg]

    CONTACT: For further information or an interview with Dr. DebbieShawcross, Investigator of the study please contact: Eleni Fistikaki +44(0)1895826227 or +44 (0)7825 389477, Clara Bentham +44 (0)1895 826654 or+44 (0)7734 367883, contact@norgine.com


    Lo más leído